[VRTX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
06-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -1.04%
YoY- 16.68%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 2,302,700 2,334,300 2,196,200 2,097,500 2,072,600 1,984,164 1,793,370 18.08%
PBT 1,076,800 1,176,400 1,024,400 954,800 870,900 1,082,741 -44,255 -
Tax 257,900 245,900 213,900 192,700 100,800 230,813 -111,179 -
NP 818,900 930,500 810,500 762,100 770,100 851,928 66,924 428.58%
Tax Rate -23.95% -20.90% -20.88% -20.18% -11.57% -21.32% - -
Total Cost 1,483,800 1,403,800 1,385,700 1,335,400 1,302,500 1,132,236 1,726,446 -9.57%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 35.56 39.86 36.90 36.33 37.16 42.94 3.73 347.76%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 3.19 3.63 3.17 2.99 3.02 3.30 0.26 429.53%
EPS Diluted 3.15 3.59 3.13 2.96 3.00 3.28 0.26 425.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.